Skip to main content
. Author manuscript; available in PMC: 2021 May 3.
Published in final edited form as: Biomed Pharmacother. 2020 Dec 8;133:111058. doi: 10.1016/j.biopha.2020.111058

Figure 5: GSC-specificity of mitochondrial inhibitors compared to human primary astrocytes.

Figure 5:

Human primary astrocytes do not show any prominent toxicity when incubated with mitochondrial inhibitors such as (A, D) Oligomycin A; (B, E) Antimycin A; and (C,F) Rotenone at the anti-GSC antiproliferative concentrations. (A-C) 0827 glioma cell line and astrocytes. (D-F) 0923 glioma cell line and astrocytes. Data are presented as average ± std. dev from 3 independent experiments (N=3).